B

Labcorp Holdings Inc. LH

$311.54 $4.581.49% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Laboratory Corporation of America Holdings (Labcorp) is a global life sciences company operating primarily in the healthcare services, clinical diagnostics, and drug development industries. The company provides laboratory-based diagnostic testing services to physicians, hospitals, health systems, government agencies, and managed care organizations, while also supporting pharmaceutical and biotechnology companies across the drug development lifecycle. Its business model combines large-scale diagnostic testing with contract research and development services, making it a vertically integrated provider across clinical care and life sciences research.

Labcorp’s primary revenue drivers are its Diagnostics Laboratories segment, which delivers routine and specialized clinical testing, and its Biopharma Laboratory Services segment, which supports clinical trials and drug development through its Covance platform. The company is strategically positioned through its scale, national laboratory network, broad test menu, and long-standing relationships with healthcare providers and life sciences companies. Labcorp traces its origins to 1978, when it was founded as Laboratory Corporation of America, and it has expanded significantly through acquisitions, most notably the acquisition of Covance Inc. in 2015, which transformed the company into a diversified life sciences services provider.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Wednesday, August 5, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Oct 26 and 30 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

Corporate Info

Phone Number
--
Address
531 South Spring Street
Burlington, NC 27215
Country
Year Founded

Headlines

9/8/2026 - Nasdaq News: Markets